UnitedHealth Group announced that Andrew Witty will step down as CEO due to “personal reasons.” He is being replaced by Stephen J. Hemsley, who served as the company’s CEO from 2006 to 2017. The post How Social Media Is Reacting to UnitedHealth Group’s CEO Exit and Stock Meltdown appeared first on MedCity News.
[Sponsored] The webinar, sponsored by PurpleLab and scheduled for May 22, will explore how healthcare sector companies can leverage real world data (RWD) with a focus on lung cancer. The post Using RWD to Improve Clinical Trial Recruitment, Endpoints, and Inform Market Access Strategies appeared first on MedCity News.
In a conversation focused on the technology underlying AI in health care, Chip is joined by Seema Verma, former administrator of the Centers for Medicare & Medicaid Services (CMS), and now Executive Vice President and General Manager at Oracle Health and Life Sciences, the second largest electronic health records (EHR) platform in the U.S. Seema shares her insights on the evolution of EHRs and why it’s necessary to redesign these systems to better…
Dr. Timothy Showalter talks about how AI can be a powerful force in recommending treatment for cancer patients. He is Artera’s chief medical officer and the company has built a digital pathology tool for prostate cancer patients. The post MedCity Pivot Podcast: How AI Can Help in Cancer appeared first on MedCity News.
Seasonal work. Inconsistent hours. Frequent moves. Cash payments and informal jobs. For farmworkers who rely on Medicaid, these common employment patterns could put their health coverage at risk. It’s a heightened concern for the estimated million-plus farmworkers who are U.S. citizens or legal permanent residents, as new work requirements kick in for the federal-state healthcare…
The post Tetanus Vaccine Symptoms and side effects appeared first on Medifyhome.
Here’s why we need stricter oversight, independent third-party testing, more rigorous research and a cultural shift in how we think about ‘natural’ remedies. The post I Trusted A Popular Supplement — It Shut Down My Liver appeared first on MedCity News.
Merck said topline Phase 3 results show an injectable version of Keytruda met the main goal of non-inferiority compared to the intravenously infused formulation that is the pharma giant’s top-selling product. Injectable Keytruda could help Merck compete against coming competition from biosimilars. The post Merck Gets a Shot of Confidence From Pivotal Test of SubQ…
Today, people living with diabetes have several ways of monitoring glucose levels, whether through finger pricks or CGMs. Both ways of measuring glucose levels have benefits and limitations. The post The Future of Glucose Monitoring: Why Blood-Based Measurements Matter appeared first on MedCity News.
This report examines the ongoing challenges and experiences of people who have been previously incarcerated. Results from KFF’s Racism, Discrimination, and Health survey show that adults with prior incarceration have significant health needs, are socially isolated, and have limited access to health care.